Micro Emerging Active

Eli Lilly AJ1-11095 development

New narrative with limited coverage — still forming.

Score
0.5
Velocity
▲ 1.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Apr 27, 2026
Eli Lilly To Buy Ajax Therapeutics To Advance AJ1-11095 Development Neutral

Related Articles

Eli Lilly To Buy Ajax Therapeutics To Advance AJ1-11095 Development

Nasdaq · Apr 27, 2026
Mixed

Timeline

Last UpdatedApr 27, 2026